The research reports on China Healthcare, Regulatory and Reimbursement Landscape Market Report gives detailed overview of factors that affect global business scope. China Healthcare, Regulatory and Reimbursement Landscape Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. China Healthcare, Regulatory and Reimbursement Landscape Market report contains emerging players analyze data including competitive situations, sales, revenue and market share of top manufacturers.
Get FREE PDF Sample of the report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=267435
China Healthcare, Regulatory and Reimbursement Landscape Market Report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of China. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.
The Chinese pharmaceutical industry – comprising the manufacturing of Western Medicines, Active Pharmaceutical Ingredients (API), Traditional Chinese Medicine (TCM), Biologics and Herbal Medicines – was valued at $168.6 billion in 2010 and grew to $424.6 billion in 2016. In 2010, the pharmaceutical market for western medicine was worth $53.8 billion, which increased to $106 billion in 2016 at a CAGR of 12%. It is forecast to be $132.9 billion in 2018 and reach $209 billion by 2022. The Chinese medical device market was valued at $36 billion in 2015, which increased to $40.1 billion in 2017. Since 2015, the China Food and Drug Administration (CFDA) has released several policies to reform the pharmaceutical market. Reforms to clinical trial processes have helped to reduce R&D costs and time, while initiatives for the market authorization process have helped to minimize regulatory delays.
Scope of this Report-
The report provides information on the healthcare, regulatory, and reimbursement landscape in the China, and includes –
– An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Merck, Novartis, Jiangsu Hengrui Medicine, Sinopharm and Tong Ren Tang) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Abbott, Roche, Boston Scientific and Shinva)
– Detailed analysis about recent completed deals in the pharmaceutical and medical device market of China
– Porters five forces analysis for pharmaceutical and medical devices market of China
– An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
– Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
– An overview of the opportunities for and challenges to growth in the Chinese healthcare market.
Reasons to buy this Report-
This report will enhance your decision-making capability by allowing you to –
– Develop business strategies by understanding the trends shaping and driving the Chinese healthcare market
– Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
– Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
– Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
– Identify, understand, and capitalize on the opportunities and challenges in the Chinese healthcare market.
Get FLAT 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=267435
Table of Contents in this Report-
Overview of Pharmaceutical Market
Overview of Medical Device Market
Porters Five Forces Model
Country Healthcare Landscape
Opportunities and Challenges